Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Marion Subklewe is Head of the Laboratory for Translational Cancer Immunotherapy at the Gene Center, Munich and Professor of Internal Medicine at Ludwig Maximilian University of Munich, Germany. She studied medicine at University Hospital Tübingen and completed her postdoctoral fellowship at Rockefeller University in New York. Professor Subklewe is current Head of the Immunotherapy Program in Haematology and the CAR T Program at University Hospital Munich, Founder and Speaker of the national “Harmonize MRD Flow” Consortium and member of the ELN Working group on MRD. She is also active in clinical research and has been Principal Investigator in 3 I-IT trials in AML and ALL, as well as in over 30 oligo- and multicentric Phase I trials in leukemia and lymphoma. In recognition of her work, Professor Subklewe has received numerous honors and awards including the EHA Educational Presentation and ASH Abstract Achievement Awards.